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Global DNA demethylation is an integral part of re-
programming processes in vivo and in vitro, but
whether it occurs in the derivation of induced pluripo-
tent stem cells (iPSCs) is not known. Here, we show
that iPSC reprogramming involves both global and
targeted demethylation, which are separable mecha-
nistically and by their biological outcomes. Cells at in-
termediate-late stages of reprogramming undergo
transient genome-wide demethylation, which is more
pronounced in female cells. Global demethylation
requires activation-induced cytidine deaminase
(AID)-mediated downregulation of UHRF1 protein,
and abolishing demethylation leaves thousands of
hypermethylated regions in the iPSC genome. Inde-
pendently of AID and global demethylation, regulatory
regions, particularly ESC enhancers and super-en-
hancers, are specifically targeted for hypomethylation
in association with transcription of the pluripotency
network. Our results show that global and targeted
DNA demethylation are conserved and distinct re-
programmingprocesses,presumablybecauseof their
respective roles in epigenetic memory erasure and in
the establishment of cell identity.INTRODUCTION
Induced pluripotent stem cell (iPSC) technology holds unparal-
leled promise for research, tissue engineering, and regenerative
medicine. Reprogramming is a continuous process character-
ized by the stepwise activation of fundamental pluripotency
genes (Brambrink et al., 2008; Stadtfeld et al., 2008) and the
silencing of somatic cell-of-origin genes (Buganim et al., 2012).Cell Rep
This is an open access article undThis complex remodeling of transcriptional networks is associ-
ated with reprogramming of the epigenome (Brambrink et al.,
2008; Sridharan et al., 2009; Stadtfeld et al., 2008), which is
the ensemble of DNA or chromatin modifications linked with
gene expression states without affecting DNA sequence. Spe-
cific histone marks are lost (Chen et al., 2013b; Golipour et al.,
2012; Yang et al., 2014) or acquired (Buganim et al., 2012; Cac-
chiarelli et al., 2015; Mikkelsen et al., 2008) during reprogram-
ming, and activation of microRNAs (Polo et al., 2012) and long
noncoding RNAs (Kim et al., 2015) at defined stages is also
important. A critical role for DNA demethylation in complete
and robust reprogramming of terminally differentiated cells has
been proposed (Papp and Plath, 2013); however, the molecular
mechanisms underlying this epigenetic process and its dy-
namics at different stages during reprogramming are poorly un-
derstood. It is also not clear to what extent demethylation is
involved in the creation of a pluripotent cell identity and whether
it may also be needed to remove epigenetic memory.
iPSCs have been shown to tolerate global hypomethylation,
just as embryonic stem cells (ESCs) do (Wernig et al., 2007),
and the efficiency of obtaining these cells is improved by treat-
ment with 5-azacytidine (Mikkelsen et al., 2008). Tet family diox-
ygenases hydroxylate 5-methylcytosine (5mC) and enhance
reprogramming efficiency (Costa et al., 2013; Doege et al.,
2012; Hu et al., 2014). The cytosine deaminase activation-
induced cytidine deaminase (AID) stabilizes the pluripotent
phenotype (Kumar et al., 2013) and is needed for demethylation
of specific promoters in heterokaryon reprogramming (Bhutani
et al., 2010), but the extent, timing, and mechanisms of this de-
methylation in iPSC reprogramming are not known.
Despite demethylation being critical, there are only a few
comprehensive studies of DNA methylation dynamics during
the reprogramming process and none in a primary reprogram-
ming system. Polo et al. (2012), using a methylation array to
study promoter regions, showed that demethylation occurs
gradually, while new methylation marks are gained only late in
reprogramming. More recently, Lee et al. (2014a) performedorts 18, 1079–1089, January 31, 2017 ª 2017 The Author(s). 1079
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genome-wide analyses in intermediates of F-class cells (an alter-
native pluripotent state, dependent on continuous high expres-
sion levels of the Yamanaka Factors [Oct3/4, Sox2, Klf4, cMyc]
OSKM) and one late time point where OSKM were no longer
exogenously expressed. They demonstrated that hypomethy-
lated differentially methylated regions (DMRs) are highly en-
riched in H3K4me3 andH3K27me3 and that themajority of these
overlap with specific transcription factor binding sites. However,
it is not clear how DNA methylation marks at regulatory regions
are remodeled during primary iPSC reprogramming and how
this is linked to the establishment of the pluripotent gene expres-
sion program. Here, we perform a comprehensive genome-wide
in-depth analysis of the dynamics of DNA demethylation and its
link to transcription during primary mouse embryonic fibroblast
(MEF) reprogramming to iPSCs. We demonstrate that both fe-
male and male cells undergo global hypomethylation of the
genome, which is likely to be important for the removal of epige-
netic memory. Independently, targeted loss of DNA methylation
marks at critical regulatory regions is necessary for the establish-
ment of cell identity. We show that global demethylation is more
pronounced in female cells, while targeted demethylation at reg-
ulatory regions is evident in both female and male cells. Finally,
we find that AID plays a key role in global demethylation and
epigenetic memory erasure. Surprisingly, this occurs at the level
of regulation of UHRF1 protein, an essential component of the
DNA methylation maintenance machinery, recently also shown
to be regulated during global demethylation in ESCs transition-
ing from serum to 2i (von Meyenn et al., 2016).
RESULTS
iPSC Reprogramming Triggers Transient Global DNA
Hypomethylation
To enable dynamic methylation profiling, reprogramming inter-
mediates were analyzed at defined time points (Figure 1A; for a
detailed description, see Experimental Procedures). Oct4-GFP
MEFs were reprogrammed in low oxygen (5% O2), known to
improve reprogramming (Yoshida et al., 2009), in serummedium
and using an inducible piggybac system. This allowed us to
obtain and pick colonies as early as day 6 (d6) after induction
of OSKM by doxycycline (Dox) and analyzing these same clones
over time, allowing for the characterization of intermediate time
points that are not accessible through primary reprogramming
carried out in normoxic conditions (Figure 1A). Female and
male iPSC clones at intermediate-late stages of reprogramming
(d21 and d29 iPSCs) already express the majority of the pluripo-
tency factors, but in contrast to established iPSCs (d60 iPSCs)
female cells are still in the process of downregulating Xist and
thus in the process of completing X chromosome reactivation
(Figure S1A). Dox-independent GFP-positive colonies at d21
that showed expression of key pluripotency markers and the
ability to differentiate into the three germ layers as well as a
normal karyotype by d60 (Figures S1B–S1D) were used in subse-
quent analyses. Embryonic stem cells (ESCs) were included in
the analysis as a control for pluripotent cells.
Notably, liquid chromatography mass spectrometry (LC-MS)
revealed substantial global demethylation in intermediate-late
stages of reprogramming in female cells (Figure 1B). While1080 Cell Reports 18, 1079–1089, January 31, 2017methylation levels comparable to MEFs (3.0%) were maintained
at d6 (d6T+/S–: 3.0% and d6T–/S+: 3.1%), in intermediate-late
stages there was a significant decrease in 5-methylcytosine
(5mC) levels (d21 iPSCs: 2.7% and d29 iPSC: 2.4%, p < 0.05:
MEFs versus d29 iPSCs, ANOVA with Dunnett’s correction).
However, this global hypomethylation was transient with estab-
lished iPSCs’s 5mC levels (3.8%) similar to those of primed ESCs
(3.9%). Global demethylation during reprogramming of female
cells was confirmed by whole-genome bisulphite sequencing
(WGBS), which revealed a substantial drop in CpG methylation
levels from 68% in MEFs to 45% in d29 iPSCs, with subsequent
remethylation to 67% in d60 iPSCs (Figures 1C, S1E, and S1G).
Interestingly, during reprogramming of male cells this global
demethylation was not as marked as in female cells (Figures
1D, S1F, and S1G).
The methylation dynamics during iPSC reprogramming
closely resembled the transient loss of DNA methylation marks
in early embryo development, where DNAmethylation is globally
lost from the oocyte (52%) to the 2- and 4-cell stage (47% and
38%) until it reaches very low levels (20%) in the inner cell
mass (ICM) at the blastocyst stage. Methylation marks are then
regained by the E6.5 epiblast stage (61%) (Figures 1E and
S1H). Moreover, global demethylation was uncoupled from
transcriptional regulation (Figure S1I) as previously reported in
primordial germ cell (PGCs) development, and in the transition
from primed to naive ESCs (Seisenberger et al., 2012; Ficz
et al., 2013).
These results show that global DNA demethylation occurs in
the intermediate-late stages of reprogramming and that female
and male cells undergo different modulation of DNA methylation
dynamics during reprogramming.
Stable Targeted DNA Demethylation Occurs at
Pluripotency Regulatory Regions and Correlates with
Expression of the Pluripotency Network
In order to integrate and validate the differences in global methyl-
ation levels observed between the discrete time points within our
experiment, the development of specific analytical approaches
was required. These approaches also allowed insights into other
reprogramming systems, thus highlighting their usefulness (for
detailed description, see Supplemental Experimental Proced-
ures). The first approach employs a background model to cor-
rect for global methylation differences, which allowed us to
confidently call differentially methylated regions (DMRs) from
MEFs to established iPSCs. Gene bodies, intergenic regions,
and long interspersed nuclear elements (LINEs) and short inter-
spersed nuclear elements (SINEs) have a similar methylation
profile to the genome as a whole and hence follow the global de-
methylation and remethylation event (Figures 2A and S2A). In
contrast, intracisternal A particle (IAP) retrotransposons and
limb enhancers (as an example of a tissue-specific enhancer)
are protected from demethylation, with many DMRs being hy-
permethylated in the established iPSCs. Notably, pluripotency
regulatory regions such as promoters, ESC enhancers, and su-
per-enhancers (SEs) are specifically targeted for demethylation,
with the majority of these DMRs being hypomethylated over and
above the genome average (Figures 2A and S2A). The impor-
tance of hypomethylation for enhancer and SE function in
A B
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Figure 1. Global DNA Demethylation Dynamics during iPSC Reprogramming
(A) Scheme of the reprogramming system. d6T+/S– and d6T–/S+: Thy1 (T) and SSEA1 (S) FACS cells at day 6 of reprogramming. For detailed description, refer to
Experimental Procedures.
(B) Global 5mC levels measured by LC-MS. Results are expressed as percentage of total cytosines and data are represented asmean ± SEM p values shown are
the result of an ANOVA with Dunnett’s correction.
(C–E) CpGmethylation levels, as assessed by BS-seq, during reprogramming of (C) female, (D) male cells, and (E) pre-implantation embryo (oocyte, 2- and 4-cell
embryos, ICM, and epiblast). (C–E) Plot displays the median (bar), inter-quartile range (box), and maximum and minimum (whiskers).
See also Figure S1.ESCs is well documented (Ding et al., 2015; Stadler et al., 2011;
Wiench et al., 2011) but has not been described in iPSC reprog-
ramming. To validate the DMRs found fromWGBS, an amplicon-
based assay was designed. This assay allowed the methylation
dynamics of selected regions to be interrogated at >1,000-fold
sequencing depth. The results closely matched those obtained
from our low sequencing depth (3-fold) WGBS data, showing
that such coverage nevertheless provided robust methylome in-
formation on individual loci (Figure S2B). Unlike global demethy-
lation, targeted demethylation occurs at the same regions and to
a similar extent during female and male somatic cell reprogram-
ming (Figure 2A).
Hierarchical clustering of RNA sequencing (RNA-seq) data of
female cells during reprogramming showed that differentially ex-
pressed genes from MEFs to established iPSCs fell into fivedistinct expression clusters (Figure S2C) similar to those previ-
ously described (O’Malley et al., 2013). Notably, genes in cluster
II (upregulated during reprogramming—including the pluripo-
tency network genes) are enriched for hypomethylated DMRs
in non-CGI promoters, ESC enhancers, and SEs (Figure 2B).
Conversely, limb enhancer DMRs, which remain hypermethy-
lated, are absent from this cluster. In contrast, genes in cluster
V (downregulated during reprogramming) are exclusively en-
riched for DMRs at limb enhancers (Figure 2B). Similar results
were seen for d6T–/S+ and ESCs (Figure S2D), showing that up-
regulation of pluripotency genes precedes global demethylation
and is influenced by targeted demethylation at ESC enhancers
and super-enhancers. Instructive examples of changes in regu-
latory regions of individual genes are shown in Figures 2C, 2D,
S2E, and S2F. These results show that demethylation at specificCell Reports 18, 1079–1089, January 31, 2017 1081
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Figure 2. Correlation of DNA Methylation at Different Regulatory Regions and Gene Expression
(A) Scatterplot of DNAmethylation levels of individual probes genome-wide, showingwhole genome and different genomic features of MEFs and d60 iPSCs. Dots
represent individual 50 CpG probes—significant differentially methylated regions (DMRs) are represented in green (female cell reprogramming) or blue (male cell
reprogramming). Background model depicted as a black line.
(B) Percentage of DMRs at regulatory regions that overlap with specific gene clusters, compared to random sets with the same number of genes (in gray).
(legend continued on next page)
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regulatory regions is important for the upregulation of the plurip-
otency network genes. In established female and male iPSCs,
depletion of methylation in ESC enhancers and non-CGI pro-
moters was more pronounced in highly and very highly ex-
pressed genes (Figure 3A), in agreement with previous studies
in ESCs (Lister et al., 2009; Stadler et al., 2011).
We developed a second analytical approach that utilizes
methylation-matched random probes (MMRPs) to account for
global methylation differences, which allows for clear visualiza-
tion of methylation differences during iPSC reprogramming (rela-
tive to MEFs). This approach validates the targeted demethyla-
tion findings in both female and male cells (Figures S3A and
S3B), and more importantly it allows for statistical significance
to be calculated after grouping of the differences elicited by re-
programming, irrespective of the differences in the process or
the genome coverage and sequencing depth of the data. Based
on these analyses, we observed that DNA demethylation at ESC
enhancers and super-enhancers is already evident in the inter-
mediate-late stages of reprogramming but becomes yet more
pronounced in d60 iPSCs (Figures 3B, 3C, S3C, and S3D).
Notably, we identified targeted demethylation at these same reg-
ulatory regions in pre-implantation embryos and during the
serum to 2i transition (Figure 3D) while it was absent in unipotent
PGCs (Surani, 2012). These results reveal a conserved targeted
demethylation signature during reprogramming to pluripotent
cell identity in vitro and in vivo, which seems to be independent
of the extent of global DNA demethylation.
AID Regulates UHRF1 and Global Demethylation during
iPSC Reprogramming
To understand the molecular regulation of global demethylation
associated with female cell reprograming, we assessed the
expression levels of genes implicated in DNA methylation and
demethylation. As previously shown (Buganim et al., 2012;
Polo et al., 2012), all Dnmt genes were significantly upregulated
upon reprogramming (Figure S4A). Importantly, we also
confirmed upregulation of DNMT1 and DNMT3b proteins (Fig-
ures 4A and S4B). However, we observed one notable exception
to this pattern UHRF1, responsible for the recruitment of DNMT1
to hemi-methylated DNA (Bostick et al., 2007; Sharif et al., 2007).
While its transcription was upregulated by reprogramming, we
observed substantially reduced protein levels at the stages
associated with global hypomethylation (Figures 4A and 4B),
when compared to fully reprogrammed iPSCs.
AID has been previously implicated in iPSC reprogramming,
but the timing, mechanisms, and extent of demethylation it
may regulate are unknown (Bhutani et al., 2013; Kumar et al.,
2013). It was therefore interesting to note that Aid expression
peaked precisely in d29 iPSCs (Figure 4C) when DNA methyl-
ation levels are lowest. Moreover, global demethylation during
reprogramming of female Aid knock-out (AidKO) MEFs was
much less substantial and was delayed when compared to(C) Expression profiles (reads per kilobase pre million mapped reads [RPKM]) fo
(D) Example of BS-seq profile for Tdgf1, Gdf3, Dppa3, and Slc2a3 at promoter, e
and 100% are shown. Shadowed areas highlight promoter (P), enhancer (E), or s
See also Figure S2.wild-type (WT) female cell reprogramming (Figures 4D, 4E,
S4C, and S4D). Typical reprograming-induced demethylation
in female cells was partially rescued by re-expression of
either the wild-type or a catalytically mutant isoform of AID,
but not by expression of an empty vector (Figure 4F). These
results show the importance of AID in regulating global DNA
demethylation during reprogramming and that this regulation is
independent of the deaminase activity of AID.
Given the marked abrogation of demethylation observed dur-
ing reprograming of female AidKO MEFs, and the downregula-
tion of UHRF1 protein associated with reprograming and global
hypomethylation inWT cells, we compared UHRF1 protein levels
during WT versus AidKO cell reprograming. Intriguingly, defi-
ciency in AID prevented the downregulation of UHRF1 protein
(Figures 4G and 4H). In addition, overexpression of AID (both
WT and deaminase mutant) in AidKO reprogramming cells led
to a significant decrease in UHRF1 protein levels (Figures 4I
and 4J), consistent with a role for AID in regulating its abundance
at a posttranscriptional level and reinforcing its importance in
regulating global demethylation. We note in this respect the dif-
ferential expression of genes involved in ubiquitination (which is
known to regulate UHRF1 [Chen et al., 2013a]) between WT and
AidKO d29 iPSCs (Figure S4E), which included Lonrf3, Mdm2,
Usp48, Pramel7, Rnf32, Shprh, and Trim17 among others.
It is notable that despite the profound defect in the transient
global demethylation associated with reprograming, we de-
tected no differences in global methylation levels between WT
and AidKO d60 iPSCs, presumably due to the de novo methyl-
ation wave that takes place at the later stages of reprograming.
However, targeted demethylation at ESC-specific enhancers
and super-enhancers was not affected by lack of AID (Figure 4K)
consistent with the fact that in general activation of the pluripo-
tency transcriptional program occurred normally in AidKO iPSCs
(Figure S4F). This is consistent with the mild effects of AID defi-
ciency on obtaining iPSCs (Habib et al., 2014; Shimamoto et al.,
2014). However we did identify more than 17,000DMRs in AidKO
iPSCs, most of which (72%) were hypermethylated (Figure S4G).
These hypermethylated DMRs occur throughout the genome
and in all genomic features, consistent with a global effect of
AID. Additionally, these cells appear to have impaired differenti-
ation potential, as they are unable to upregulate several differen-
tiation markers at the same levels as WT cells (Figure S4H).
These findings reconcile previous observations on AidKO iPSCs
(Kumar et al., 2013), showing that global demethylation is mech-
anistically uncoupled from targeted demethylation and is neces-
sary for the erasure of epigenetic memory.
Our data also showed significant upregulation of the ten-
eleven Translocation (Tet) Tet1 and Tet2, and Tdg genes in
d29 iPSCs (Figure S4I) that continue to be highly expressed in
fully reprogrammed iPSCs. Hydroxymethylation levels were
low in MEFs and d6T+/S– cells, in contrast to d6T–/S+ cells
that have hydroxymethylation levels similar to primed ESCsr Tdgf1, Gdf3, Dppa3, and Slc2a3.
nhancer, and SE regions. Methylation levels of individual probes, between 0%
uper-enhancer (SE) regions.
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(Figure S4J). This increase in 5-hydroxymethylcytosine (5hmC)
correlates with the observed increase in expression of the Tet
enzymes, consistent with their role in controlling MET (Hu
et al., 2014). Furthermore, the expression dynamics of Tet1, 2
and Tdg are consistent with a possible role in targeted but not
in global demethylation.
Finally, based on the observation that female and male cells
undergo global DNA demethylation to different extents, and
when female cells are devoid of AID they show an extent of
global demethylation similar to male WT cells, we investigated
the status of X chromosome reactivation. We observed that
AidKO female cells are able to reactivate the X chromosome,
just like WT cells (Figure S4K). Furthermore, to exclude that
this could be a reprogramming system-specific effect, we re-
programmed fibroblasts from one male and four female human
donors. Human cells also undergo global demethylation during
reprogramming (Figure S4L). However, this demethylation is
not as profound as in female mouse cells, resembling more
closely the male mouse global DNA methylation profile. Since
human cells do not robustly reactivate the X chromosome during
iPSC reprogramming (Tchieu et al., 2010), we investigated
whether this was the case in our reprogramming system. We
observed that our human cells were not able to reactivate the
X chromosome and Xist expression was maintained (Figures
S4M and S4N). Moreover, we observed that Aid is expressed
at d11, when methylation levels are lower (Figure S4O).
These results suggest that global DNA demethylation during
reprogramming is mainly achieved by passive demethylation,
similar to what has been reported in other reprogramming pro-
cesses (Seisenberger et al., 2012). Furthermore, AID can influ-
ence the global methylation levels during reprograming by regu-
lating the protein levels of UHRF1, and thus the efficiency of
recruitment of the maintenance methylation machinery. Addi-
tionally, the extent of global DNA demethylation is not dependent
on the reprogramming system or species but seems to be influ-
enced by the capacity of cells to reactivate the X chromosome
(Figure 4L).
DISCUSSION
The extent and role of DNAmethylation remodeling during the re-
programming of somatic cells to pluripotency are poorly under-
stood. Our detailed and comprehensive study reveals that iPSCs
undergo transient global demethylation during reprogramming
and that stable targeted demethylation occurs in parallel to the
global one. Notably, we show that the targeted and global deme-
thylation processes are mechanistically uncoupled and that up-
regulation of pluripotency genes precedes and is not dependent
on the extent of global demethylation. Targeted demethylationFigure 3. DNA Demethylation Dynamics at Specific Genomic Features
(A) CpG methylation levels for promoter and enhancer regions of genes showing
(B and C) Density plots of methylation differences from MEFs to each time point in
shown by opaque plots, overlaid by MMRP transparent gray density plot.
(D) Density plots of methylation differences at specific features, from oocyte to e
ESCs, shown by opaque plots; overlaid byMMRP transparent gray density plot. (B
5% difference between data and MMRP profile. p values shown are the result o
See also Figure S3.establishes a unique epigenetic pluripotency signature, which
is broadly conserved in other reprogramming processes. An
important caveat is that there are gender-specific differences
in the extent to which the genome demethylates globally. In fe-
male cells, where DNA demethylation is more pronounced,
downregulation of UHRF1 protein, through an AID-dependent
mechanism, facilitates global but not targeted demethylation
(Figure 4L). Moreover, our results clearly show that cells lacking
AID-mediated global demethylation have an impaired differenti-
ation potential, showing that AID is important for epigenetic
memory erasure but not for the establishment of pluripotent
cell identity.
Global DNA demethylation occurs in early embryos, during
PGC development and in naive ESCs in both mouse and human
(von Meyenn and Reik, 2015) and has consequently been pro-
posed to be a conserved and obligate feature of reprogramming
(Lee et al., 2014b; Nashun et al., 2015). Here, we show that
mouse female and male cells undergo different levels of
genome-wide demethylation during iPSC reprogramming. Our
results, extrapolated from human cell reprogramming, point to
a role for X chromosome reactivation in influencing these differ-
ences. This is consistent with mouse female ESCs having lower
global methylation levels than male ones (Zvetkova et al., 2005)
and with a recent report in PGC-like cell induction, where female
cells undergo DNA methylation reprogramming similar to male
cells, however, with more pronounced global changes (Shirane
et al., 2016).
We reprogramMEFs to iPSCs in the presence of serum, which
in ESCs results in high global methylation levels similar to those
of somatic cells (Ficz et al., 2013; Habibi et al., 2013; Leitch et al.,
2013). Hence despite high levels of de novo methyltransferases,
controlled downregulation of UHRF1 protein seems critical for
global demethylation. We have recently shown that UHRF1 is
also regulated at the protein level when mouse ESCs are transi-
tioned from serum to 2i (vonMeyenn et al., 2016). This potentially
provides a unifying theme for genome-wide demethylation
mechanisms, which in mice and humans are characterized by
disabling of the UHRF1/DNMT1 system, including by posttran-
scriptional regulation of Uhrf1 (Seisenberger et al., 2012; Su-
gawa et al., 2015).
The role of AID in DNA demethylation and reprogramming
in vivo and in vitro has been puzzling with the majority of studies
demonstrating that it plays a role in demethylation (Bhutani et al.,
2010, 2013; Kumar et al., 2013; Popp et al., 2010; Santos et al.,
2013) but that it has mild impact on iPSC reprogramming (Habib
et al., 2014; Shimamoto et al., 2014). Our results clearly show
that AID plays a major role in global DNA demethylation, and un-
expectedly this seems to be brought about by its negative regu-
lation of UHRF1 protein levels, suggesting a novel role for AID inand in Different Reprogramming Processes
different expression levels in female d60 iPSCs.
reprogramming of (B) female and (C) male cells and ESCs, at specific features
ach time point in pre-implantation embryo, epiblast to PGCs and serum to 2i
–D) Analyses were performed for ESC enhancers and SED denotes aminimum
f a pairwise t test with a Benjamini-Hochberg correction.
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Figure 4. Mechanisms of DNA Demethylation
(A) WB showing levels of DNMT1 and UHRF1 in WT iPSCs at d29 and d60. b-actin was used as a loading control.
(B) Quantitation of DNMT1 and UHRF1 WB bands, relative to ESCs levels.
(C) Expression profile (RPKM) for Aid. p values shown are the result of two-tailed t tests from MEFs to d29 iPSCs.
(D) Global 5mC levels, measured by LC-MS. Results are expressed as percentage of total cytosine. Data are represented as mean ± SEM. Shown are results for
reprogramming of WT and AidKO MEFs.
(E) Global CpG methylation levels, as assessed by BS-seq, for every time point during AidKO MEF reprogramming. Plot displays the median (bar), inter-quartile
range (box), and maximum and minimum (whiskers).
(F) Global 5mC levels, measured by LC-MS. Results are expressed as percentage of total cytosine. Data are represented as mean ± SEM. Shown are results for
AidKO MEFs reprogrammed with the OSKM plus an empty vector (EV), a vector containing AID WT cDNA (AIDWt), or a vector containing AID catalytic mutant
cDNA (AIDCatMutt).
(G) WB showing levels of DNMT1 and UHRF1 in AidKO iPSCs at d29 and d60. b-actin was used as a loading control.
(H) Quantitation of DNMT1 and UHRF1 WB bands, relative to ESCs levels.
(I) WB showing levels of UHRF1 in WT and AidKO iPSCs d29 and clones rescued with EV, AIDWtor AIDCatMutt. b-actin was used as a loading control.
(J) Quantitation of UHRF1 WB bands (arbitrary units [a.u.]).
(legend continued on next page)
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posttranslational regulation of UHRF1. Known mechanisms of
UHRF1 regulation that can affect DNA methylation include ubiq-
uitination among others (Tauber and Fischle, 2015). We note in
this respect that several ubiquitination and deubiquitination en-
zymes are differentially expressed in iPSCs with and without
AID, and that AID itself interacts with a ubiquitin ligase (Sun
et al., 2013).
Targeted demethylation (over and above the global demethy-
lation) occurs at ESC-specific enhancers and super-enhancers
to a similar extent in female and male cells, and this is conserved
in other reprogramming processes in which pluripotent cell iden-
tity is achieved. These regions share the characteristics of being
CpG-poor and transcription factor (TF) binding-rich regions,
characteristics that have been proposed to play a role in focal
or targeted demethylation (Soufi et al., 2012; Stadler et al.,
2011). TET proteins have also been implicated in reprogramming
(Nashun et al., 2015), as well as in targeted enhancer (Pastor
et al., 2013) and super-enhancer (Ding et al., 2015) demethyla-
tion in ESCs. However, Tet enzymes are needed specifically
for activation of microRNAs essential for iPSC derivation, and it
is possible to obtain fully reprogrammed iPSCs from Tet1-3
triple-knockout MEFs after ectopic expression of miR200c (Hu
et al., 2014). Nevertheless, the dynamics of Tet enzyme expres-
sion and of the hydroxymethylation levels that we observe sug-
gest they may play a role in the fine-tuning of targeted demethy-
lation. Indeed, a model that seeks to explain DNA methylation
dynamics at enhancers during differentiation has been proposed
(Hon et al., 2014). This model suggests that at TF binding-rich
enhancers, binding of TFs excludes DNMT1 activity, leading to
their demethylation, whereas in TF binding-poor enhancers,
TET2 protein is crucial in fine-tuning enhancer methylation in
an oxidation-dependent manner. We suggest that a similar
mechanism could be responsible for the targeted remodeling
of these regions during reprogramming.
In contrast, AID does not have a role in targeted demethylation
of pluripotency regulatory regions, but its absence results in
widespread hypermethylated epialleles in iPSCs. This explains
why AID-deficient iPSCs can be obtained, but cells with residual
and persistent epigenetic memory may well behave aberrantly
and unpredictably in potential future therapeutic settings, given
their altered differentiation potential. It will be interesting to
investigate further the differences in developmental potential be-
tween female andmale iPSCs, which could impact on their use in
basic and translational research. Hence, in a process where cells
have to switch off a somatic expression program and upregulate
a pluripotency network, global DNA demethylation seems to be
important for the removal of epigenetic memory, while targeted
demethylation at regulatory regions, and, in particular, at ESC
super-enhancers, is crucial for the establishment of the pluripo-
tent identity. Understanding and manipulating the two demethy-
lation processes may result in improvements in the safety and(K) Density plots of methylation differences at ESC enhancer and SE from AidKO
density plot. D denotes a minimum 5% difference between data and MMRP profi
correction.
(L) Proposed model to explain role of AID in DNA methylation dynamics during iP
See also Figure S4.the efficiency of obtaining robust, high quality iPSCs, prerequi-
sites for therapeutic applications in regenerative medicine.
EXPERIMENTAL PROCEDURES
Reprogramming of MEFs to iPSCs
For each transfection, 0.83 106 MEFs were nucleofected using Amaxa Nucle-
ofection Technology (Lonza AG; program A-023), according to the manufac-
turer’s instructions, with 1 mg of each plasmid. Plasmids for reprogramming
pB-TRE-OCKS, pBASE, and pB-CAG-rtTA were obtained from the Wellcome
Trust Sanger Institute’s plasmid repository. Reprogramming was performed in
ESC medium (DMEM, 15% fetal bovine serum, 1% anti-anti, 1% MEM non-
essential amino acids, 50 mM b-mercaptoethanol, and 103 U leukemia inhibi-
tory factor [LIF]) in the presence or absence of doxycycline, in a 5% O2
incubator. The medium was refreshed every other day. Colonies were picked
on day 6 of reprogramming and expanded for at least 54 days. Cells were
collected at different time points during reprogramming: mouse embryonic
fibroblasts (MEFs), d6 fluorescence-activated cell sorted (FACS) refractory
cells positive for Thy1 and negative for SSEA1 surface markers (d6T+/S–),
and early reprogramming intermediates negative for Thy1 and positive for
SSEA1 (d6T–/S+) as well as the reprogramming of individual colonies at inter-
mediate-late stages of reprogramming (d21 iPSC and d29 iPSC) and estab-
lished iPSCs (d60 iPSC).
All animal work carried out in this study is covered by a project license under
the Animal (Scientific Procedures) Act 1986, and further regulated by the Bab-
raham Institute Animal Welfare, Experimentation, and Ethics Committee.
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